David A. Happel
2017
In 2017, David A. Happel earned a total compensation of $1.9M as Executive Vice President, Commercial Development and Strategy at Horizon Pharma, a 21% increase compared to previous year.
Compensation breakdown
| Bonus | $1,085,000 |
|---|---|
| Non-Equity Incentive Plan | $241,750 |
| Salary | $500,000 |
| Other | $77,000 |
| Total | $1,903,750 |
Happel received $1.1M in bonus, accounting for 57% of the total pay in 2017.
Happel also received $241.8K in non-equity incentive plan, $500K in salary and $77K in other compensation.
Rankings
In 2017, David A. Happel's compensation ranked 5,740th out of 14,666 executives tracked by ExecPay. In other words, Happel earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,740 out of 14,666 | 61st |
Division Manufacturing | 2,085 out of 5,770 | 64th |
Major group Chemicals And Allied Products | 648 out of 2,074 | 69th |
Industry group Drugs | 499 out of 1,730 | 71st |
Industry Pharmaceutical Preparations | 394 out of 1,329 | 70th |
Source: SEC filing on April 2, 2018.
Happel's colleagues
We found six more compensation records of executives who worked with David A. Happel at Horizon Pharma in 2017.
2017
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2017
Irina Konstantinovsky
Horizon Pharma
Chief Human Resources Officer
2017
Barry Moze
Horizon Pharma
Chief Administrative Officer
2017
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2017
Robert Carey
Horizon Pharma
Executive Vice President, Chief Business Officer
2017
Vikram Karnani
Horizon Pharma